Cargando…

Changes in targeted metabolomics in lung tissue of chronic obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common chronic lung disease and its incidence is steadily increasing. COPD patients and mouse models of COPD share some similarities in lung pathology and physiology. We performed this study to explore the potential metabolic pathways inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yi, Xie, Meiqin, Liu, Qi, Weng, Jiali, Wei, Liangyu, Chung, Kian Fan, Adcock, Ian M., Chang, Qing, Li, Mengnan, Huang, Yan, Zhang, Hai, Li, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267913/ https://www.ncbi.nlm.nih.gov/pubmed/37324094 http://dx.doi.org/10.21037/jtd-22-1731

Ejemplares similares

Attenuation of PM(2.5)-induced alveolar epithelial cells and lung injury through regulation of mitochondrial fission and fusion
por: Liu, Qi, et al.
Publicado: (2023)

Role of TRPA1/TRPV1 in acute ozone exposure induced murine model of airway inflammation and bronchial hyperresponsiveness
por: Li, Chenfei, et al.
Publicado: (2022)

Integrated analysis reveals lung fibrinogen gamma chain as a biomarker for chronic obstructive pulmonary disease
por: Zhang, Hai, et al.
Publicado: (2021)

Effects of N-Acetylcysteine in Ozone-Induced Chronic Obstructive Pulmonary Disease Model
por: Li, Feng, et al.
Publicado: (2013)

Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease
por: Durham, Andrew L., et al.
Publicado: (2016)

Mitochondrial dysfunction in airways and quadriceps muscle of patients with chronic obstructive pulmonary disease
por: Haji, Gulam, et al.
Publicado: (2020)

Oxidative Stress in Ozone-Induced Chronic Lung Inflammation and Emphysema: A Facet of Chronic Obstructive Pulmonary Disease
por: Wiegman, Coen H., et al.
Publicado: (2020)

Trends in prevalence, mortality, and disability-adjusted life-years relating to chronic obstructive pulmonary disease in Europe: an observational study of the global burden of disease database, 2001–2019
por: Marshall, Dominic C., et al.
Publicado: (2022)

TRPV1 and TRPA1 in Lung Inflammation and Airway Hyperresponsiveness Induced by Fine Particulate Matter (PM(2.5))
por: Xu, Mengmeng, et al.
Publicado: (2019)

Glucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary disease
por: Marwick, John A, et al.
Publicado: (2010)

Profile of fluticasone furoate/vilanterol dry powder inhaler combination therapy as a potential treatment for COPD
por: Caramori, Gaetano, et al.
Publicado: (2014)

Transcriptional Effects of Ozone and Impact on Airway Inflammation
por: Mumby, Sharon, et al.
Publicado: (2019)

Roles of mitochondrial ROS and NLRP3 inflammasome in multiple ozone-induced lung inflammation and emphysema
por: Li, Feng, et al.
Publicado: (2018)

Sputum myeloperoxidase in chronic obstructive pulmonary disease
por: Zhu, Alling, et al.
Publicado: (2014)

Cytokine inhibition in the treatment of COPD
por: Caramori, Gaetano, et al.
Publicado: (2014)

Differentiation in TCM patterns of chronic obstructive pulmonary disease by comprehensive metabolomic and lipidomic characterization
por: Li, Jiansheng, et al.
Publicado: (2023)

Oxidative stress–induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease
por: Wiegman, Coen H., et al.
Publicado: (2015)

Corticosteroids
por: Caramori, Gaetano, et al.
Publicado: (2019)

PGAM5 expression and macrophage signatures in non-small cell lung cancer associated with chronic obstructive pulmonary disease (COPD)
por: Ng Kee Kwong, F., et al.
Publicado: (2018)

An evaluation of activity tolerance, patient-reported outcomes and satisfaction with the effectiveness of pulmonary daoyin on patients with chronic obstructive pulmonary disease
por: Zhang, Hai-long, et al.
Publicado: (2017)

Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Qibai Pingfei capsule on chronic obstructive pulmonary disease
por: Xie, Jinghui, et al.
Publicado: (2023)

Immunological Features of Chronic Obstructive Pulmonary Disease (COPD) Induced by Indoor Pollution and Cigarette Smoke
por: Mortaz, Esmaeil, et al.
Publicado: (2012)

Metabolomic changes in patients with chronic obstructive pulmonary disease with abnormal Savda syndrome
por: XU, WEI-FANG, et al.
Publicado: (2015)

Cigarette Smoke Exposure Alters mSin3a and Mi-2α/β Expression; implications in the control of pro-inflammatory gene transcription and glucocorticoid function
por: Marwick, John A, et al.
Publicado: (2010)

Correction to: Research Cigarette Smoke Exposure Alters mSin3a and Mi-2α/β Expression; implications in the control of pro-inflammatory gene transcription and glucocorticoid function
por: Marwick, John A., et al.
Publicado: (2021)

Is mitochondrial dysfunction a driving mechanism linking COPD to nonsmall cell lung carcinoma?
por: Ng Kee Kwong, Francois, et al.
Publicado: (2017)

Metabolomics of chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: response to Maniscalco and Motta
por: Mlynarz, P., et al.
Publicado: (2016)

An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary Disease
por: Ran, Nan, et al.
Publicado: (2019)

Disease-associated gut microbiome and metabolome changes in patients with chronic obstructive pulmonary disease
por: Bowerman, Kate L., et al.
Publicado: (2020)

BET Bromodomains Regulate Transforming Growth Factor-β-induced Proliferation and Cytokine Release in Asthmatic Airway Smooth Muscle
por: Perry, Mark M., et al.
Publicado: (2015)

Metabolomics Analysis of Different Tissues of Lonicera japonica Thunb. Based on Liquid Chromatography with Mass Spectrometry
por: Wang, Yan, et al.
Publicado: (2023)

Anti-Pulmonary Fibrosis Activities of Triterpenoids from Oenothera biennis
por: Liu, Juanjuan, et al.
Publicado: (2022)

Models of chronic obstructive pulmonary disease
por: Groneberg, David A, et al.
Publicado: (2004)

The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease
por: Pragman, Alexa A., et al.
Publicado: (2018)

Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics
por: Kilk, Kalle, et al.
Publicado: (2018)

N6-methyladenosine-methylomic landscape of lung tissues of mice with chronic obstructive pulmonary disease
por: Hu, Tingting, et al.
Publicado: (2023)

Outdoor particulate matter exposure affects metabolome in chronic obstructive pulmonary disease: Preliminary study
por: Yu, Tao, et al.
Publicado: (2023)

Yifei Sanjie Formula Treats Chronic Obstructive Pulmonary Disease by Remodeling Pulmonary Microbiota
por: Wu, Yueying, et al.
Publicado: (2022)

Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease
por: Zhou, Juntuo, et al.
Publicado: (2020)

Self-Efficacy Intervention Programs in Patients with Chronic Obstructive Pulmonary Disease: Narrative Review
por: Yi, Qi-Feng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v2vugsad87ciah61p75gc9sk2a